Who
Maxwell Krakowiak
Please See Remarks
Company insider
Files Form 4 as: Please See Remarks, Revvity.
In numbers
- Trades disclosed
- 31
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $513K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Sep 2022
- Last trade
- 21 Sep 2026
- Last filed
- 23 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Sep 2026filed 23 Sep 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Sold | $236K1,631 at $144.53 | filing |
| 21 Sep 2026filed 23 Sep 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Sold | $236K1,631 at $144.53 | filing |
| 17 Feb 2026filed 19 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code F | $140K1,457 at $96.03 | filing |
| 17 Feb 2026filed 19 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code F | $87K902 at $96.03 | filing |
| 17 Feb 2026filed 19 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code F | $140K1,457 at $96.03 | filing |
| 17 Feb 2026filed 19 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code F | $87K902 at $96.03 | filing |
| 4 Feb 2026filed 6 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code F | $72K708 at $101.13 | filing |
| 4 Feb 2026filed 6 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code A | —7,262 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | RVTY Revvityoption or derivative · Life-science tools | SEC FORM 4 Code A | —20,771 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | RVTY Revvityoption or derivative · Life-science tools | SEC FORM 4 Code A | —20,771 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code F | $72K708 at $101.13 | filing |
| 4 Feb 2026filed 6 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code A | —7,262 at $0.00 | filing |
| 15 Sep 2025filed 17 Sep 2025 | RVTY RevvityLife-science tools | SEC FORM 4 Code F | $46K559 at $82.87 | filing |
| 15 Aug 2025filed 18 Aug 2025 | RVTY Revvityoption or derivative · Life-science tools | SEC FORM 4 Code A | —44,446 at $0.00 | filing |
| 18 Feb 2025filed 19 Feb 2025 | RVTY RevvityLife-science tools | SEC FORM 4 Code F | $5,61350 at $112.26 | filing |
| 4 Feb 2025filed 6 Feb 2025 | RVTY Revvityoption or derivative · Life-science tools | SEC FORM 4 Code A | —15,784 at $0.00 | filing |
| 4 Feb 2025filed 6 Feb 2025 | RVTY RevvityLife-science tools | SEC FORM 4 Code A | —5,709 at $0.00 | filing |
| 15 Feb 2024filed 16 Feb 2024 | RVTY RevvityLife-science tools | SEC FORM 4 Code F | $3,62535 at $103.56 | filing |
| 15 Feb 2024filed 16 Feb 2024 | RVTY RevvityLife-science tools | SEC FORM 4 Code F | $5,17850 at $103.56 | filing |
| 5 Feb 2024filed 7 Feb 2024 | RVTY Revvityoption or derivative · Life-science tools | SEC FORM 4 Code A | —28,028 at $0.00 | filing |
News
Codexis (NASDAQ:CDXS) and Revvity (NYSE:RVTY) Head-To-Head ComparisonRVTY · themarketsdaily.com · 19 Oct 2026Revvity (NYSE:RVTY) Stock Sale Disclosed by Rep. Gilbert Ray Cisneros, Jr.RVTY · dailypolitical.com · 14 Oct 2026Rep. Gilbert Ray Cisneros, Jr. Sells Shares of Revvity Inc. (NYSE:RVTY)RVTY · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Maxwell Krakowiak; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.